Welcome to Patents and Trademarks Guide
Expired Patents Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
US Patent and Trademark Office in a Nutshell
from:Deb St. George, on Patents and Trademarks in your Patent and Trademark Guide From Agritrax.com
You might have heard a couple of times the words patent and trademark. Though you have a vague idea of its relation to commercial products and to your favorite icon, you may have not wholly grasped what it really is and who has the authority to grant trademarks and patents. You have this fuzzy idea that it somehow protects products from piracy problems and helps distinguish the forged product from the real one.
A patent is a group of limited rights given by the state to the patentee or inventor for a certain period of time in barter for the controlled public exposé of information about the invention, composition of a substance, which can be very useful to the industry or can be commercially popular. The grant will be exclusive only to the patentee thwarting off other individuals from legally manufacturing and or selling off the patented product.
Trademark, on the other hand, is any unique symbol or logo which can be utilized by an individual or organization to promote their merchandise and services to consumers. Trademark can be consisted of logos, symbols, design, icons, word, phrase, name or a amalgamation of these essentials.
The USPTO or United States Patent and Trademark Office is the agency that controls trademarks and patents registered in the United States.
The United States Patent and Trademark Office is a U.S. Department of Commerce organization. The USPTO basically endow patents to register trademarks and protect inventions. This organization provides service for the interests of commerce and inventors as well as their business products, inventions, and their service identifications. It also serves various government agencies when it comes to issues concerning domestic and international facets of intellectual properties. The USPTO upholds the development of the country's technology and industry, as well as fortifying the economy.
The USPTO was created by the United States Congress mainly for the purpose of granting patents for the benefit of the government. Back in the year 1802, the Patent Office was a separate agency in the Department of State. It was then when an official of the office was called Superintendent of Patents. The Patent office was eventually restructured after the amendment of patent laws in the year 1836, the officer in charge became known as Commissioner of Patents.
The office stayed on the wings of the Department of State until it was reassigned to the Department of Interior in 1849. Then it was relocated to the Department of Commerce in 1925 up to the present day.
The name Patent Office itself underwent some forms of evolutions. In 1975, its name was altered into Patent and Trademark Office. But then again, it was changed in the year 2000 into the United States Patent and Trademark Office, which the name still remains as of the present day.
The Under Secretary of Commerce for Intellectual Property is the chief and director of the USPTO. As the chief of the said agency, the Director is in charge in the supervision of tasks in relation to the issuing and granting patent. The Director also supervises the listing of trademarks, sets down policies and regulations, which are subject to the authorization of the Secretary of Commerce, for the performance of the proceedings of the Office. The Under secretary also tackles a variety of issues carried out before the Office by appeal as imposed by the policies and regulations. The USPTO chief has other duties that are required for the Office's administration.
Although the chief of the USPTO may have huge responsibilities on his or her shoulders, the workload of probing applications for patents are shared by several examining technology centers or TC.
Each examining technology center have their own control over each fields assigned to their center. The TC is led by an assemblage of directors, examiners, and support staff. The examiners study the application for patents and decide if a patent can be granted. These same examiners also make out applications that may claim identical inventions and may well start proceedings to settle on which inventor came with the invention first. The TC may or may not grant a patent but an appeal can be brought to the Board of Patent Appeals. The Director of the USPTO may review the case and he or she may have the final say about the matter.
You have something original in mind? Have the USPTO patent it and have them recognize your trademark.
Expired Patents News
Bristol Myers Squibb Anticipates Significant Decline In Sales In The US For ... - PR Web (press release)
Bristol Myers Squibb Anticipates Significant Decline In Sales In The US For ... PR Web (press release) Patents in family which claim the Clopidogrel molecule per se, have already expired. However, protection has been extended to 17 May 2012 in the US. The term of the equivalent European patent has also been extended by supplementary protection ... |
Novartis Sues Lupin, Torrent Over Blood-Pressure Medicine - Bloomberg
Novartis Sues Lupin, Torrent Over Blood-Pressure Medicine Bloomberg Lupin, based in Mumbai, and Torrent, based in Ahmedabad, India, are seeking to make generic versions of the drug before the expiration of two patents. Novartis requested a court order barring the companies from making, using or offering for sale copies ... |
Pernod Ricard, Kodak, Apple, Novartis: Intellectual Property - BusinessWeek
Pernod Ricard, Kodak, Apple, Novartis: Intellectual Property BusinessWeek Novartis requested a court order barring the companies from making, using or offering for sale copies of the drugs until the patents have expired, according to complaints filed yesterday in federal court in Wilmington, Delaware. |
Patents Versus Access to Drugs - AllAfrica.com
Patents Versus Access to Drugs AllAfrica.com The validity of the patent is at the centre of the dispute with Cipla alleging it is invalid because it is essentially not a new drug. The product patent on the medicine has expired. The outstanding patent relates "to a composition of unpatented ... |
Section27, TAC join big pharma bust-up over cancer drug - Mail & Guardian Online
 Mail & Guardian Online | Section27, TAC join big pharma bust-up over cancer drug Mail & Guardian Online The patent on Docetaxel expired in 2007 and the case concerns a “composition of unpatented products” used to administer Docetaxel. This patent expires next year. Aventis argued that Cipla infringed its patent rights but in a case heard last year, ... TAC call for cancer drug to be cheaper |
4 Big Pharma Stocks To Nab In A Pullback - Seeking Alpha
4 Big Pharma Stocks To Nab In A Pullback Seeking Alpha Merck (MRK) beat consensus earnings estimates in the most recent quarter by one cent and continues to enjoy a modest but steady rise in share value, even though its apex breadwinner, Singulair, is winding its way to a US patent expiration on August 3rd ... |
Jury set to consider patent claims in Oracle-Google Java trial - V3.co.uk
Jury set to consider patent claims in Oracle-Google Java trial V3.co.uk Google had previously offered Oracle $2.8m in patent-related damages as well as a small cent share of Android's future revenues until the patents expired. Oracle rejected that offer, and must wait to see if the jury is more generous. |